Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer Growth. > Journals | InnoAbs Laboratory

Publication Innovative Antibodies Laboratory

Journals

Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer Growth.
Author
Jeoung MH, Kim TK, Kim JW, Cho YB, Na HJ, Yoo BC, Shim H, Song DK, Heo K, Lee S
Journal
Biomolecules
Status
pii: E681
Vol
doi: 10.3390/biom9110681
Page
11
Year
2019
.